Roivant Sciences Ltd.(NasdaqGS:ROIV) added to S&P 400 - Biotechnology (Industry)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.25 USD | +0.36% | +0.09% | +0.18% |
05/04 | Arbutus Biopharma Obtains Favorable Court Order in Moderna Patent Lawsuit | MT |
04/04 | Moderna Suffers Setback in Lawsuit by Arbutus | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.18% | 9.03B | |
+32.36% | 698B | |
+26.51% | 568B | |
-4.40% | 358B | |
+19.46% | 328B | |
+3.50% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.62% | 165B |
- Stock Market
- Equities
- ROIV Stock
- News Roivant Sciences Ltd.
- Roivant Sciences Ltd.(NasdaqGS: ROIV) added to S&P 400 - Biotechnology